Also trades as: SHWZ.NE (NEO) · $vol 0M
SHWZ OTC
Medicine Man Technologies, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -90.0%
1Y: -99.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$172M
+8.2% ▲
5Y CAGR: +85.2%
Gross Profit
$76M
-10.6% ▼
5Y CAGR: +70.0%
Operating Income
$3M
-74.4% ▼
5Y CAGR: +8.7%
Net Income
-$35M
-87.1% ▼
EPS (Diluted)
$-0.26
+46.9% ▲
EBITDA
$38M
+0.2% ▲
5Y CAGR: +88.3%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $11M | $24M | $108M | $159M | $172M |
| YoY Growth | +34.0% | +126.0% | +351.7% | +47.0% | +8.2% |
| Cost of Revenue | $8M | $17M | $59M | $74M | $96M |
| Gross Profit | $3M | $7M | $49M | $85M | $76M |
| Gross Margin | 28.3% | 28.2% | 45.5% | 53.4% | 44.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $16M | $30M | $39M | $59M | $71M |
| Operating Expenses | $16M | $30M | $39M | $67M | $73M |
| Operating Income | -$13M | -$23M | $10M | $13M | $3M |
| Operating Margin | -126.8% | -95.4% | 9.6% | 8.1% | 1.9% |
| Interest Expense | $192K | $41K | $7M | $30M | $32M |
| Income Before Tax | -$18M | -$20M | $19M | -$4M | -$15M |
| Tax Expense | -$583K | -$899K | $4M | $15M | $20M |
| Net Income | -$17M | -$19M | $15M | -$18M | -$35M |
| Net Margin | -159.9% | -80.9% | 13.4% | -11.6% | -20.0% |
| EPS (Diluted) | $-0.50 | $-0.47 | $-0.06 | $-0.49 | $-0.26 |
| EBITDA | -$13M | -$20M | $35M | $38M | $38M |
| Shares Outstanding | 34M | 41M | 43M | 54M | 65M |